enGene Inc.

NASDAQ: ENGN · Real-Time Price · USD
3.70
0.09 (2.49%)
At close: Aug 15, 2025, 3:59 PM
3.68
-0.54%
After-hours: Aug 15, 2025, 04:10 PM EDT

enGene Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 175K n/a n/a
Gross Profit
n/a -175K n/a n/a
Operating Income
62.3M -26.06M -19.43M -15.87M
Interest Income
10.41M 1.12M 129K 25K
Pretax Income
55.16M -99.9M -24.44M -225K
Net Income
55.14M -99.92M -24.46M -23.44M
Selling & General & Admin
23.98M 9.43M 3.26M 3.15M
Research & Development
38.31M 16.46M 15.47M 12.46M
Other Expenses
n/a n/a -393K n/a
Operating Expenses
62.3M 25.89M 19.43M 15.87M
Interest Expense
2.8M 4.95M 1.42M 5.02M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
62.3M 26.06M 19.43M 15.87M
Income Tax Expense
-19K 17K 22K 4.9M
Shares Outstanding (Basic)
44.64M 23.56M 15.81M 15.81M
Shares Outstanding (Diluted)
44.64M 23.56M 15.81M 15.81M
EPS (Basic)
1.24 -4.24 -1.55 -1.48
EPS (Diluted)
1.24 -4.24 -1.55 -1.48
EBITDA
62.3M -94.77M -19.45M -15.7M
EBIT
57.96M -94.95M 30.73K -225K
Depreciation & Amortization
323K 175K 238K 272K